2 active not recruiting, 1 recruiting, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 2, Recruiting 1, Unknown 1 |
Follow Carcinosarcoma: new trials by email Literature Review of Carcinosarcoma trials Research Report on Carcinosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer Biospecimen Collection, Diagnostic Imaging Testing, Excisional Biopsy - Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 | Phase 3 | Recruiting | NRG Oncology | 428 | 2022-12-07 | 2026-11-06 |
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer Biospecimen Collection, Brachytherapy, Computed Tomography - Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 164 | 2020-04-09 | 2026-07-02 |
| Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer Carboplatin, Computed Tomography, Paclitaxel - Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 813 | 2019-08-22 | 2026-11-13 |
| Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Carboplatin, Ifosfamide, Paclitaxel - Mixed Mesodermal (Mullerian) Tumor, Ovarian Carcinosarcoma | Phase 3 | Unknown | GOG Foundation | 637 | 2009-08-17 | 2021-09-30 |
Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Complex and Mixed (4) · Neoplasms, Connective and Soft Tissue (4) · Sarcoma (4) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Adnexal Diseases (1) · Endocrine Gland Neoplasms (1)
Carboplatin (2) · Paclitaxel (2) · Specimen Handling (2) · Taxes (2) · X-Rays (2) · pembrolizumab (2) · Biopsy (1) · Brachytherapy (1) · Congresses as Topic (1) · Ifosfamide (1) · Indocyanine Green (1) · Magnetic Resonance Spectroscopy (1) · Minimally Invasive Surgical Procedures (1) · Phantoms, Imaging (1) · Radiation (1)
National Cancer Institute (NCI) (2) · GOG Foundation (1) · NRG Oncology (1)
United States (4) · South Korea (3) · Puerto Rico (2) · Canada (1) · Japan (1)
Edward J Tanner (1) · Floor Backes (1) · Matthew A Powell (1) · Ramez N Eskander (1)
PMID 34340209, PMID 35007153, PMID 36972022, PMID 37411031, PMID 38431043, PMID 40044930, PMID 40966692
U10CA180868 (3), U10CA027469 (1), UG1CA189867 (1)